Notícias do Mercado de Ações
Últimas notícias financeiras · Atualizado Mai 23, 2026
Apple Completa 50 Anos: De Startup de Garagem a Gigante de US$ 3,73 Trilhões — Veja Quanto Valeria Hoje um Investimento de US$ 1.000 em sua IPO
Apple Turns 50: From Garage Startup To $3.73 Trillion Giant—Here's How Much A $1,000 Investment At Its IPO Would Be Worth Today
The panelists generally agreed that Apple's current valuation and future growth prospects are uncertain, with significant risks and opportunities ahead.
Eu Perguntei ao ChatGPT Para Explicar Ethereum para Mim Como se Eu Tivesse 12
I Asked ChatGPT To Explain Ethereum to Me Like I’m 12
The panel discussion on Ethereum's investment thesis highlights significant competition from other chains, regulatory risks, and the need for further …
Keir Starmalade, alguém? A geleia terá realmente que ser renomeada no Reino Unido?
Keir Starmalade, anyone? Will marmalade really have to be rebranded in UK?
The panel generally agrees that the marmalade labeling change is a non-event for major UK food companies, with some long-term …
‘Não exatamente Greggs’: Criadores do TikTok testam padarias ‘gentrificadas’ de Londres
‘Not quite Greggs’: TikTok creators put London’s ‘gentrified’ bakeries to the test
The panel's net takeaway is that while these premium-priced, artisanal bakeries benefit from TikTok-driven visibility, their long-term resilience and profitability …
Goldman Sachs aumenta sua meta de preço para PVH Corp. (PVH) para $93 de $83
Goldman Sachs Raises its Price Target on PVH Corp. (PVH) to $93 from $83
The panelists had a mixed view on PVH's outlook, with some flagging risks like EMEA softness, reliance on margin expansion, …
Ascendis Pharma A/S (ASND) Relata Dados Positivos do Semana 52 do Ensaio de Fase 2 New InsiGHTS
Ascendis Pharma A/S (ASND) Reports Positive Week 52 Data from Phase 2 New InsiGHTS Trial
The panel discusses ASND's Week 52 Phase 2 data showing TransCon hGH's non-inferiority to daily somatropin, with YUVIWEL's EMA approval …
Wolfe Research Inicia Cobertura da BeOne Medicines AG (ONC) com Rating Outperform
Wolfe Research Initiates Coverage of BeOne Medicines AG (ONC) with Outperform Rating
The panel is neutral on BeOne Medicines (ONC), with concerns about Brukinsa's long-term margins due to generic competition and uncertainty …
Mizuho Reduz o Preço-Alvo da Autolus Therapeutics plc (AUTL) para US$ 10 de US$ 12
Mizuho Lowers its Price Target on Autolus Therapeutics plc (AUTL) to $10 from $12
The panelists debated AUTL's outlook, with some highlighting its strong Q4 results and potential for 2026 inflection, while others raised …
Galapagos NV (GLPG) Assina Acordo com Gilead sobre Ativos de Medicamentos Ouro
Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets
GLPG's partnership with Gilead on gamgertamig provides a pipeline extension and potential near-to-mid-term catalyst, but the deal's true value lies …
RBC Capital reduz sua meta de preço para Bicycle Therapeutics plc (BCYC) de $11 para $7
RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11
BCYC's one-time revenue from terminated partnerships masks a pivot away from zelenectide due to regulatory feedback, reducing near-term commercialization visibility. …
Os Melhores ETFs Para Petróleo a $100 Para Comprar Agora
The Best ETFs For $100 Oil To Buy Right Now
The panel consensus is that while $105 WTI is driven by geopolitical risks, it may not be sustained due to …
TD Cowen aumenta sua meta de preço para Marex Group plc (MRX) para $66 de $61
TD Cowen Raises its Price Target on Marex Group plc (MRX) to $66 from $61
Panelists are divided on Marex Group (MRX). Bulls highlight record revenue beats and potential re-rating, while bears question the sustainability …